Abel Hall LLC
MRVI icon

Abel Hall LLC’s Maravai LifeSciences MRVI Stock Holding History

Abel Hall LLC’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$91K Sell
11,884
-213
-2% -$1.47K 0.02% 790
2026
Q2 		$75.5K Sell
12,097
-811
-6% -$3.5K 0.01% 869
2026
Q1 		$36.5K Buy
12,908
+1,292
+11% +$4.38K 0.01% 765
2025
Q4 		$37.8K Buy
11,616
+136
+1% +$458 0.01% 675
2025
Q3 		$32.9K Buy
+11,480
New +$29.3K 0.01% 307

Other funds holding MRVI

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Dynamic Wealth Strategies
Dynamic Wealth Strategies Granite Bay, California $188M AUM 12.25% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Abel Hall LLC's MRVI Position: Q3 2026 in Review

Abel Hall LLC reduced its Maravai LifeSciences (MRVI) stake by 1.8% in Q3 2026, selling an estimated $1.47K and leaving 11,884 shares worth $91K. The position accounts for 0.02% of the portfolio, ranked #790.

Abel Hall LLC first reported a position in MRVI in Q3 2025 and has held it in 5 quarters since. 14 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Abel Hall LLC held 11,884 shares of Maravai LifeSciences worth $91K as of Q3 2026.
  • Abel Hall LLC sold 213 Maravai LifeSciences shares in Q3 2026, an estimated $1.47K.
  • Maravai LifeSciences made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #790 holding.
  • Abel Hall LLC first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 5 quarters since.
  • 14 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.